Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

OncoMed Pharmaceuticals reports phase Ia results on OMP-305B83

Dec. 28, 2016

MSD seeks approval of additional indication for Keytruda in Japan

Dec. 27, 2016

First patient enrolled in LTX-315 anti-PD-1 combination study

Dec. 27, 2016

A-000830 is a promising novel small-molecule inhibitor of ecto-nucleotidase CD73

Dec. 27, 2016

European Commission grants orphan drug designation to AM-0010 for pancreatic cancer

Dec. 23, 2016

Incyte and Merus collaborate on bispecific antibodies

Dec. 23, 2016

Avastin receives orphan drug designation in Japan

Dec. 23, 2016

Triphase Accelerator and Celgene enter new collaboration

Dec. 23, 2016

BioInvent and Pfizer sign cancer immunotherapy research collaboration and license agreement

Dec. 23, 2016

PsiOxus Therapeutics and BMS sign exclusive worldwide license agreement for NG-348

Dec. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...